LAXMIDENTL

Laxmi Dental Limited

Laxmi Dental Limited (LAXMIDENTL) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies

laxmidentallimited.com

Ask AI

Key metrics

Price as of 2026-10-16

Stock price

₹184.72

Market cap

1,017 Cr

Stock P/E

32.9

P/B

4.17

ROE (FY26)

11.9%

ROCE (FY26)

13.4%

Operating margin (FY26)

9.9%

Debt / equity (FY26)

0.00

OCF / EBITDA (FY26)

-11.5%

OCF / EBITDA (3Y)

43.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Laxmi Dental makes custom dental prosthetics such as crowns, clear aligners and digital dentistry products for dentists, dental clinics and dental companies in India and in about 95-100 countries.

Company snapshot

5thBy market cap

Ranked among 8 companies in Medical Equipment & Supplies.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 71.6% of revenue

Segment	Revenue share	Revenue	PBT	Assets
Aligners Business	36.6%	65 Cr	13 Cr	—
Laborartory Business	71.6%	128 Cr	17 Cr	—
Other Business	5.7%	10 Cr	0.97 Cr	—

Shares add up to 114% because segment revenues are before inter-segment eliminations.

What we see

Positives

✓Debt-to-equity of 0.00x — the company is largely funded by its own money, not borrowed funds.

Concerns

✗Only 43% of operating profit came in as cash over the last three years — much of it is tied up in unpaid bills or stock.

1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

Metric	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026
Sales	62 Cr	61 Cr	66 Cr	72 Cr	66 Cr	74 Cr	75 Cr
Operating expenses (approx.)	52 Cr	51 Cr	54 Cr	61 Cr	59 Cr	60 Cr	60 Cr
EBITDA	10 Cr	10 Cr	12 Cr	11 Cr	7 Cr	14 Cr	14 Cr
OPM %	15.6%	15.7%	18.2%	15.3%	10.5%	18.3%	19.2%
Other income	0.59 Cr	2 Cr	2 Cr	2 Cr	2 Cr	2 Cr	2 Cr
Interest	2 Cr	1 Cr	0.46 Cr	0.24 Cr	0.32 Cr	0.34 Cr	0.30 Cr
Depreciation	4 Cr	4 Cr	4 Cr	4 Cr	4 Cr	4 Cr	4 Cr
Profit before tax	6 Cr	7 Cr	11 Cr	10 Cr	-0.20 Cr	11 Cr	13 Cr
Tax %	18.2%	36.7%	21.5%	17.9%	1094.4%	4.7%	19.5%
Net profit	5 Cr	4 Cr	8 Cr	9 Cr	2 Cr	10 Cr	10 Cr
EPS (₹)	₹0.88	₹0.79	₹1.53	₹1.59	₹0.37	₹1.83	₹1.87

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	137 Cr	162 Cr	194 Cr	239 Cr	278 Cr	Sign in free for the trailing twelve months
Operating expenses (approx.)	131 Cr	153 Cr	170 Cr	197 Cr	234 Cr	Sign in free for the trailing twelve months
EBITDA	5 Cr	9 Cr	24 Cr	42 Cr	43 Cr	Sign in free for the trailing twelve months
OPM %	4.0%	5.5%	12.3%	17.5%	15.6%	Sign in free for the trailing twelve months
Other income	1 Cr	2 Cr	2 Cr	3 Cr	9 Cr	Sign in free for the trailing twelve months
Interest	4 Cr	4 Cr	5 Cr	5 Cr	1 Cr	Sign in free for the trailing twelve months
Depreciation	8 Cr	11 Cr	12 Cr	15 Cr	16 Cr	Sign in free for the trailing twelve months
Profit before tax	-15 Cr	-4 Cr	17 Cr	38 Cr	31 Cr	Sign in free for the trailing twelve months
Tax %	-16.0%	-5.1%	-54.1%	16.6%	7.9%	Sign in free for the trailing twelve months
Net profit	-19 Cr	-4 Cr	25 Cr	32 Cr	29 Cr	Sign in free for the trailing twelve months
EPS (₹)	₹-3.56	₹-0.77	₹4.80	₹6.06	₹5.53	Sign in free for the trailing twelve months
Dividend payout %	—	—	—	0.0%	0.0%	Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	0.31 Cr	0.31 Cr	0.31 Cr	11 Cr	11 Cr
Reserves	21 Cr	17 Cr	42 Cr	198 Cr	232 Cr
Borrowings	30 Cr	31 Cr	42 Cr	11 Cr	—
Other liabilities	50 Cr	46 Cr	48 Cr	65 Cr	50 Cr
Total liabilities	103 Cr	97 Cr	135 Cr	285 Cr	294 Cr
Fixed assets (net)	30 Cr	31 Cr	36 Cr	41 Cr	59 Cr
CWIP	—	—	—	0.21 Cr	0 Cr
Investments	0.15 Cr	0.30 Cr	6 Cr	10 Cr	27 Cr
Loans & advances	—	—	—	0.17 Cr	0.24 Cr
Inventories	30 Cr	24 Cr	25 Cr	19 Cr	22 Cr
Trade receivables	20 Cr	20 Cr	25 Cr	37 Cr	46 Cr
Cash & bank	1 Cr	0.96 Cr	0.70 Cr	91 Cr	8 Cr
Other assets	22 Cr	19 Cr	42 Cr	87 Cr	132 Cr
Total assets	103 Cr	97 Cr	135 Cr	285 Cr	294 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	-2 Cr	14 Cr	8 Cr	44 Cr	-5 Cr
Cash from investing	3 Cr	-9 Cr	-14 Cr	-29 Cr	-80 Cr
Cash from financing	-4 Cr	-1 Cr	0.97 Cr	111 Cr	-18 Cr
Net cash flow	-3 Cr	4 Cr	-5 Cr	125 Cr	-101 Cr
Free cash flow (OCF − Capex)	-12 Cr	4 Cr	-7 Cr	28 Cr	-23 Cr

Ratios

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROCE %	-21.5%	0.9%	25.8%	19.8%	13.4%
ROE %	-80.0%	-20.4%	55.6%	15.2%	11.9%
Debtor days	54	46	47	56	60
Inventory days	350	288	194	182	316
Days payable	317	267	124	313	155
Cash conversion cycle	88	66	117	-75	220
OCF / EBITDA %	-36.9%	161.1%	34.3%	104.7%	-11.5%
OCF / EBITDA % (3 years)	—	—	54.0%	89.0%	43.1%
Debt / equity	1.41	1.77	0.99	0.05	0.00
Current ratio	1.01	0.93	0.96	3.30	6.21
Net debt / EBITDA	5.28	3.40	1.74	-1.90	-0.19